Building the next generation of Medical Information services across Europe

To meet this need, Oriola is strengthening and expanding its Medical Information offering. What started as a trusted MI service across the Nordics and Baltics is now evolving into a scalable, multilingual and future ready MI model designed to support pharmaceutical companies across Europe.

A clear ambition: one Medical Information partner for Europe

Our ambition is clear: to become a leading Medical Information partner for pharmaceutical companies operating across the Nordics and the wider EU. We particularly support organisations managing multi country launches, growing portfolios or complex outsourcing models that require consistent, compliant and efficient MI delivery across markets.

Our European MI model is available now. It is built to support:

• Global and regional Medical Affairs leaders
• Heads of Medical Information and MI teams
• Organisations requiring harmonised MI services across multiple European markets

What distinguishes Oriola’s Medical Information approach?

“Our Medical Information is next generation because it combines human scientific expertise with AI enabled insights, scalable EU level delivery, and quality by design – built for today’s regulatory complexity and tomorrow’s growth", says Marie Kerttu, Head of Medical Information at Oriola.

• One trusted partner across multiple countries
  Instead of working with fragmented local vendors, our partners collaborate with one MI setup covering multiple countries. This ensures consistent quality, simplified vendor management and smoother operations across markets.
• Compliance you can rely on
  Scientifically trained, multilingual MI professionals with deep Nordic and EU regulatory expertise ensure compliant, high quality responses and processes.
• Scale without friction
  From fully dedicated MI teams to on demand specialists, our model is designed to flex with your needs. Support is available in local languages as well as English, enabling true multi country operations.
• Quality embedded by design
  A robust Quality Management System supports accurate intake, high quality documentation and timely adverse event and product quality complaint reporting.
• Digital efficiency and AI enabled insights
  Validated MI tools combined with newly developed AI analytics capabilities support faster onboarding, more consistent workflows and stronger insight generation from MI data.

Built on experience, ready for Europe

While the European MI model is newly established, it is built on concrete experience from existing partnerships.

In one case, a pharmaceutical company initially partnered with Oriola for MI services in a single Nordic country. Based on the quality and consistency of the delivery, the collaboration was later expanded to additional Nordic markets, demonstrating trust in both the model and its scalability.

In another example, a pharmaceutical company participated in a pilot project using Oriola’s AI based MI analytics solution. Following the pilot, the company chose to continue using the tool as part of its MI setup, recognising the value of improved insight generation and data usability.

These experiences form a strong foundation as Oriola now extends its MI readiness from a Nordic base to a broader European context.

Let’s shape the future of Medical Information together

Oriola continues to evolve its Medical Information offering in close dialogue with customers and partners. If there are capabilities or services you believe should be part of a modern, future ready MI model, we would welcome the conversation.